Rainer Henning

Company: WORG Pharmaceuticals

Job title: Chief Scientific Officer

Seminars:

The PCFiT Platform: A Promising Approach for B-Cell Directed Allergy Immunotherapy 12:00 pm

B-cell targeting fusion proteins (PCFiT™) elicit a potent allergen specific IgG response They are devoid of sensitizing and T-cell activating activity and offer short course, high-dose AIT The approach can be broadly applied to all major allergen sources, clinical proof of concept has been demonstratedRead more

day: Day Two